Decline seen in US antibiotic use since 1999, but progress has slowed
Overall short-term antibiotic use in the United States fell over the past 20 years, but progress stalled over the last decade, researchers from Johns Hopkins University School of Medicine reported today in
Open Forum Infectious Diseases.
The researchers used data from National Health and Nutrition Examination Surveys (NHANES), which ask participants about medications taken over the past 30 days and have been collected and released in 2-year intervals since 1999, to identify trends in short-term non-topical antibiotic use from 1999 to 2018. They calculated the prevalence of antibiotic use overall and by subgroups of interest for the years 1999 to 2002, 2007 to 2010, and 2015 to 2018. They also calculated antibiotic use by class and examined factors associated with antibiotic use during 2015-2018.
email article
Topic: Is it safe for heart attack patients to go to the hospital during the pandemic? Is cardiac injury common in COVID-19? Can the vaccine cause hypertension? Join
MedPage Today and Erin Michos, MD, MHS, Associate Director of Preventive Cardiology at Johns Hopkins University School of Medicine in Baltimore, live for a discussion about the evolving science on the interface of COVID-19 and cardiovascular disease.
When: Friday, May 14, at noon EDT
How to Join:Click here to be taken directly to the Facebook Live interview, which will remain viewable after the live event.
Follow us on Facebook @MedPageToday and join the interview live on our feed. Feel free to comment, ask questions, and react during the interview!
코로나19 하루 사망자 3400명 미국, 600명대로 급감했다 joins.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from joins.com Daily Mail and Mail on Sunday newspapers.
Johns Hopkins Medicine
Chronic itch – known clinically as chronic pruritus – is characterized as an unrelenting and sometimes even debilitating sensation to itch, and often lowers the quality of life for those who suffer with it. Treating the condition has been difficult because there are few Food and Drug Administration-approved therapies. Now, a recent case study by Johns Hopkins Medicine researchers provides evidence that a promising option for patients with chronic itch may already be available: medical marijuana (cannabis).
“Chronic itch can be an especially difficult condition to treat, with off-label therapeutics often utilized,” says Shawn Kwatra, M.D., assistant professor of dermatology at the Johns Hopkins University School of Medicine. “With the increased utilization of medical marijuana and our knowledge of the role of the endocannabinoid system [a complex cell-signaling system that regulates a variety of functions in the body] in chronic itch, we decided to t